Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

31,500

Employees31,500

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

31,500

Employees31,500

AMGN Key Statistics

Market cap

177.88B

Market cap177.88B

Price-Earnings ratio

23.07

Price-Earnings ratio23.07

Dividend yield

2.91%

Dividend yield2.91%

Average volume

2.96M

Average volume2.96M

High today

$334.19

High today$334.19

Low today

$327.62

Low today$327.62

Open price

$333.44

Open price$333.44

Volume

1.92M

Volume1.92M

52 Week high

$391.29

52 Week high$391.29

52 Week low

$261.43

52 Week low$261.43

Stock Snapshot

The current Amgen(AMGN) stock price is $328.78, with a market capitalization of 177.88B. The stock trades at a price-to-earnings (P/E) ratio of 23.07 and offers a dividend yield of 2.9%.

On 2026-05-11, Amgen(AMGN) stock traded between a low of $327.62 and a high of $334.19. Shares are currently priced at $328.78, which is +0.4% above the low and -1.6% below the high.

The Amgen(AMGN)'s current trading volume is 1.92M, compared to an average daily volume of 2.96M.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

AMGN News

Simply Wall St 15h

Amgen’s New Puerto Rico Biologics Investment Might Change The Case For Investing In Amgen - simplywall.st

...

TipRanks 3d

Amgen Halts Phase 2 HZN-1116 Trial in Sjögren’s: What Investors Should Know

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

TipRanks 4d

Amgen upgraded to Buy from Hold at Freedom Broker

Freedom Broker upgraded Amgen (AMGN) to Buy from Hold with an unchanged price target of $375. Amgen’s Q1 results were “fully in line with our expectations, alth...

Analyst ratings

49%

of 37 ratings

Buy

43.2%

Hold

48.6%

Sell

8.1%

More AMGN News

Simply Wall St 6d

Amgen’s Real Time FDA Trials Raise Questions On Pipeline Value

Amgen (NasdaqGS:AMGN) has been selected by the FDA as one of only two companies to run proof of concept trials under the new real time clinical trials initiativ...

Investor's Business Daily 6d

Can This Small Rival Take On Amgen's Eye Disease Blockbuster?

Technology Can This Small Rival Take On Amgen's Eye Disease Blockbuster? Licensing Viridian Therapeutics (VRDN) on Tuesday unveiled promising results for its ex...

Simply Wall St 7d

A Look At Amgen Valuation After Q1 Beat And US$300m Puerto Rico Expansion

Amgen (AMGN) is back in focus after a busy few weeks, with Q1 2026 earnings above market estimates, higher full year revenue guidance, and a fresh US$300 millio...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.